Stock Analysis
AcouSort First Quarter 2024 Earnings: kr0.25 loss per share (vs kr0.23 loss in 1Q 2023)
AcouSort (STO:ACOU) First Quarter 2024 Results
Key Financial Results
- Revenue: kr2.97m (down 23% from 1Q 2023).
- Net loss: kr3.73m (loss widened by 23% from 1Q 2023).
- kr0.25 loss per share (further deteriorated from kr0.23 loss in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
AcouSort's share price is broadly unchanged from a week ago.
Risk Analysis
Be aware that AcouSort is showing 6 warning signs in our investment analysis and 3 of those make us uncomfortable...
Valuation is complex, but we're helping make it simple.
Find out whether AcouSort is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:ACOU
AcouSort
A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.
Adequate balance sheet with weak fundamentals.